• Citer

A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer.

par Ignatiadis, Michail ;Polyzos, Aris;Stathopoulos, George GP;Tselepatiotis, Evangelos;Christophylakis, Charalambos;Kalbakis, Kostas;Vamvakas, Lambros;Kotsakis, Athanasios;Potamianou, Anna;Georgoulias, Vassilis
Référence Oncology, 71, 3-4, page (159-163)
Publication Publié, 2006

Article révisé par les pairs

• Détails
• Contenu

Titre:	A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer.
Auteur:	Ignatiadis, Michail; Polyzos, Aris; Stathopoulos, George GP; Tselepatiotis, Evangelos; Christophylakis, Charalambos; Kalbakis, Kostas; Vamvakas, Lambros; Kotsakis, Athanasios; Potamianou, Anna; Georgoulias, Vassilis
Informations sur la publication:	Oncology, 71, 3-4, page (159-163)
Statut de publication:	Publié, 2006
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Deoxycytidine -- analogs & derivatives -- therapeutic use
	Female
	Humans
	Male
	Middle Aged
	Neoplasm Metastasis
	Pancreatic Neoplasms -- drug therapy -- pathology
	Quinazolines -- administration & dosage
	Survival Analysis
	Taxoids -- administration & dosage
Langue:	Anglais
Identificateurs:	urn:issn:0030-2414
	info:doi/10.1159/000106064
	info:pii/000106064
	info:pmid/17646699